Literature DB >> 22892768

Clinical, epidemiological and mycological report on 65 patients from the Eastern Amazon region with chromoblastomycosis.

Carla Andréa Avelar Pires1, Marilia Brasil Xavier, Juarez Antônio Simões Quaresma, Geraldo Mariano Moraes de Macedo, Bruna Ranyelle de Marinho Sousa, Arival Cardoso de Brito.   

Abstract

BACKGROUND: Chromoblastomycosis is a chronic fungal infection caused by fungi from the Dematiaceae family. According to several studies, Fonsecaea pedrosoi is the most common of these fungi. The infection is more common in tropical countries, with the Brazilian state of Pará having one of the largest infected populations worldwide. The disease is difficult to treat and recurrences are common.
OBJECTIVES: To describe the epidemiological and mycological aspects of cases of chromoblastomycosis and its clinical forms in the state of Pará, Brazil.
METHODS: Mycological exams (direct mycological examinations, culture and microculture) were performed and a clinical/epidemiological evaluation was made of 65 patients receiving care at the Dermatology Department of the Federal University of Pará between 2000 and 2007. The clinical classification proposed by Carrión in 1950 was used in this study.
RESULTS: The majority of the patients were male (93.8%), agricultural workers (89.2%) of 45 to 55 years of age, and the majority of lesions (55.4%) were of the verrucous type, located principally on the lower limbs (81.5%). In the majority of the cases investigated (61.5%), the infection had been present for a long time, with a mean duration of 11 years. Direct mycological examination was performed in 86.2% of the patients (n=56). Of these, 96.4% (n=54) tested positive. Culture and microculture were performed in vitro in 47 cases of those that tested positive at direct microscopy, results showing Fonsecaea pedrosoi to be the only agent present in this sample.
CONCLUSION: This study highlighted the extent to which chromoblastomycosis still affects the quality of life of the local population, principally individuals working in agriculture. This is a chronic disease for which there is no effective treatment. The importance of continuing to investigate this disease should be emphasized, as further studies may lead to new clinical or epidemiological findings.

Entities:  

Mesh:

Year:  2012        PMID: 22892768     DOI: 10.1590/s0365-05962012000400006

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  7 in total

Review 1.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Clinical and demographic profile of chromoblastomycosis in a referral service in the midwest of São Paulo state (Brazil).

Authors:  Gabriela Franco Marques; Paula Yoshiko Masuda; Juliana Martins Prazeres Sousa; Jaison Antônio Barreto; Patrick Alexander Wachholz
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

3.  Tumoral chromoblastomycosis: a rare manifestation with typical complementary exams.

Authors:  John Verrinder Veasey; Beatriz de Abreu Ribeiro Machado; Rute Facchini Lellis; Laura Hitomi Muramatu; Clarisse Zaitz
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

4.  Chromoblastomycosis: A case series from Eastern China.

Authors:  Sujun Liu; Huilin Zhi; Hong Shen; Wenwen Lv; Bo Sang; Qiuping Li; Yan Zhong; Zehu Liu; Xiujiao Xia
Journal:  PLoS Negl Trop Dis       Date:  2022-09-26

5.  Chromoblastomycosis Associated with Bone and Central Nervous Involvement System in an Immunocompetent Child Caused by Exophiala Spinifera.

Authors:  Sahana M Srinivas; Vykuntaraju K Gowda; S Mahantesh; Rajeshwari Mannapur; Sanjay K Shivappa
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

6.  Differential distribution patterns of Fonsecaea agents of chromoblastomycosis, exemplified by the first case due to F. monophora from Argentina.

Authors:  Marcelo Label; Luciana C Karayan; Sybren De Hoog; Javier Afeltra; Togo Bustamante; Roxana G Vitale
Journal:  Med Mycol Case Rep       Date:  2017-12-08

7.  Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.

Authors:  Rowena Alves Coelho; Fábio Brito-Santos; Maria Helena Galdino Figueiredo-Carvalho; Juliana Vitoria Dos Santos Silva; Maria Clara Gutierrez-Galhardo; Antonio Carlos Francesconi do Valle; Rosely Maria Zancopé-Oliveira; Luciana Trilles; Wieland Meyer; Dayvison Francis Saraiva Freitas; Rodrigo Almeida-Paes
Journal:  PLoS Negl Trop Dis       Date:  2018-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.